Andrea Aroldi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Venues

Journal of clinical medicine

Viruses

Cancers

American journal of hematology

Harvard Medical School

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Harvard Medical School May 01 2019

United States

post-doc Fellow :: Dept. of Pathology

Azienda Ospedaliera San Gerardo Dec 10 2014

Italy

M.D. - Hem/Onc Fellow :: Dept. of Hematology and BMT

Publications

Andrea Aroldi, Mario Mauri, Daniele Ramazzotti, Matteo Villa, Federica Malighetti, Valentina Crippa, Federica Cocito, Chiara Borella, Elisa Bossi, Carolina Steidl, Chiara Scollo, Claudia Voena, Roberto Chiarle, Luca Mologni, Rocco Piazza, Carlo B Gambacorti-Passerini
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia. Journal of cellular and molecular medicine (2023)
Michele Clerico, Irene Dogliotti, Andrea Aroldi, Chiara Consoli, Luisa Giaccone, Benedetto Bruno, Federica Cavallo
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options. Journal of clinical medicine 11 (24) (2022)
Andrea Aroldi, Fabrizio Angaroni, Deborah D'Aliberti, Silvia Spinelli, Ilaria Crespiatico, Valentina Crippa, Rocco Giovanni Piazza, Alex Graudenzi, Daniele Ramazzotti
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples. Viruses 15 (1) (2022)
Andrea Aroldi, Fabrizio Angaroni, Deborah D'Aliberti, Silvia Spinelli, Ilaria Crespiatico, Valentina Crippa, Rocco Giovanni Piazza, Alex Graudenzi, Daniele Ramazzotti
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples. Viruses 15 (1) (2022)
Michele Clerico, Irene Dogliotti, Andrea Aroldi, Chiara Consoli, Luisa Giaccone, Benedetto Bruno, Federica Cavallo
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options. Journal of clinical medicine 11 (24) (2022)
Francesco Boccalatte, Roberto Mina, Andrea Aroldi, Sarah Leone, Carter M Suryadevara, Dimitris G Placantonakis, Benedetto Bruno
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors. Cancers 14 (20) (2022)
Michele Clerico, Irene Dogliotti, Andrea Aroldi, Chiara Consoli, Luisa Giaccone, Benedetto Bruno, Federica Cavallo
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options. Journal of clinical medicine 11 (24) (2022)
Andrea Aroldi, Fabrizio Angaroni, Deborah D'Aliberti, Silvia Spinelli, Ilaria Crespiatico, Valentina Crippa, Rocco Giovanni Piazza, Alex Graudenzi, Daniele Ramazzotti
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples. Viruses 15 (1) (2022)
Elisa Bossi, Andrea Aroldi, Lorenza Maria Borin, Luisa Verga, Diletta Fontana, Federica Cocito, Beatrice Manghisi, Giovanni Rindone, Fabrizio Cavalca, Alessia Ripamonti, Monica Raggi, Sergio Maria Ivano Malandrin, Annalisa Cavallero, Laura Antolini, Diego Bonardi, Rocco Giovanni Piazza, Carlo B Gambacorti-Passerini
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706). EJHaem (2022)
Michele Clerico, Irene Dogliotti, Andrea Aroldi, Chiara Consoli, Luisa Giaccone, Benedetto Bruno, Federica Cavallo
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options. Journal of clinical medicine 11 (24) (2022)
Andrea Aroldi, Fabrizio Angaroni, Deborah D'Aliberti, Silvia Spinelli, Ilaria Crespiatico, Valentina Crippa, Rocco Giovanni Piazza, Alex Graudenzi, Daniele Ramazzotti
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples. Viruses 15 (1) (2022)
Elisa Bossi, Andrea Aroldi, Filippo A Brioschi, Carolina Steidl, Silvia Baretta, Rossella Renso, Luisa Verga, Diletta Fontana, Geeta Geeta Sharma, Luca Mologni, Lara Mussolin, Rocco Giovanni Piazza, Carlo B Gambacorti-Passerini
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy. American journal of hematology 95 (12) (2020)

Andrea Aroldi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andrea Aroldi